UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Multiple sclerosis, 2010-03, Vol.16 (3), p.342-350

2010

Volltextzugriff (PDF)

A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients

Multiple sclerosis, 2006-06, Vol.12 (3), p.309-320

2006

Volltextzugriff (PDF)

Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis

Multiple sclerosis, 2008-06, Vol.14 (5), p.663-670

2008

Volltextzugriff (PDF)

Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS

Journal of neurology, 2008-10, Vol.255 (10), p.1473-1478

2008

Volltextzugriff (PDF)

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial

Neurology, 1994-06, Vol.44 (6), p.1054-1054

1994

Volltextzugriff (PDF)

Intramedullary spinal cord abscess in a healthy woman

Neurology, 2007-04, Vol.68 (15), p.1230-1230

2007

Volltextzugriff (PDF)

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis

The New England journal of medicine, 2008-10, Vol.359 (17), p.1786-1801

2008

Volltextzugriff (PDF)

Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?

Multiple sclerosis, 2009-08, Vol.15 (8), p.959-964

2009

Volltextzugriff (PDF)

Randomized study combining interferon and glatiramer acetate in multiple sclerosis

Annals of neurology, 2013-03, Vol.73 (3), p.327-340

2013

Volltextzugriff (PDF)

Exacerbations of multiple sclerosis in patients treated with gamma interferon

The Lancet (British edition), 1987-04, Vol.1 (8538), p.893-895

1987

Volltextzugriff (PDF)

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

Neurology, 2002-11, Vol.59 (10), p.1496

2002

Volltextzugriff (PDF)

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study

Neurology, 2004-11, Vol.63 (10), p.1788-1795

2004

Volltextzugriff (PDF)

Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration

Neurology, 1996-06, Vol.46 (6), p.1639-1643

1996

Volltextzugriff (PDF)

The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study

Multiple sclerosis, 1995-11, Vol.1 (3), p.165-169

1995

Volltextzugriff (PDF)

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

Lancet neurology, 2008-10, Vol.7 (10), p.903-914

2008

Volltextzugriff (PDF)

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial

Neurology, 1996-12, Vol.47 (6), p.1457-1462

1996

Volltextzugriff (PDF)

Pulmonary function in hospitalized infants and toddlers with cystic fibrosis

The Journal of pediatrics, 1998-03, Vol.132 (3), p.405-408

1998

Volltextzugriff (PDF)

Concurrence of multiple sclerosis and brain tumor: clinical considerations

Neurology, 1997-05, Vol.48 (5), p.1330-1333

1997

Volltextzugriff (PDF)

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

Multiple sclerosis, 2015-09, Vol.21 (10), p.1322-1331

2015

Volltextzugriff (PDF)

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

Neurology, 1987-07, Vol.37 (7), p.1097-1097

1987

Volltextzugriff (PDF)

Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection

Neurology, 1992-02, Vol.42 (2), p.278-278

1992

Volltextzugriff (PDF)

Relapsing transverse myelitis

Neurology, 1991-05, Vol.41 (5), p.703-706

1991

Volltextzugriff (PDF)

Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study

Human brain mapping, 2015-10, Vol.36 (10), p.3749-3760

2015

Volltextzugriff (PDF)

Epithelial modulation of preterm airway smooth muscle contraction

Journal of applied physiology (1985), 1993-03, Vol.74 (3), p.1437-1443

1993

Volltextzugriff (PDF)

Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis

Annals of neurology, 2006-05, Vol.59 (5), p.780-787

2006

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Aktive Filter

Publikationsformmagazinearticle

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(84)

Sprache

Englisch
(84)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients

Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis

Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial

Intramedullary spinal cord abscess in a healthy woman

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis

Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?

Randomized study combining interferon and glatiramer acetate in multiple sclerosis

Exacerbations of multiple sclerosis in patients treated with gamma interferon

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study

Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration

The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial

Pulmonary function in hospitalized infants and toddlers with cystic fibrosis

Concurrence of multiple sclerosis and brain tumor: clinical considerations

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection

Relapsing transverse myelitis

Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study

Epithelial modulation of preterm airway smooth muscle contraction

Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis

Aktive Filter

Suchergebnisse filtern